Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by DiagnaMed Holdings Corp.

DiagnaMed Advancing the Medical Potential of Hydrogen
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Expands with Drug and Clinical Research AI Platform
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces LIFE Offering of up to $650,000
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Launches “Health GenAI”, a New Division for Generative AI Healthcare Solutions
From Diagnamed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
From Diagnamed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with CERVAI™, a Brain Health AI Platform Leveraging Generative AI
From Diagnamed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED
DiagnaMed Prioritizes Development and Commercialization Initiatives for CERVAI™, a Brain Health AI Platform Leveraging Generative AI
From Diagnamed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED
DiagnaMed Holdings Incorporates OpenAI’s ChatGPT into BRAIN AGE™ AI Product Suite
From Diagnamed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED
DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023
From Diagnamed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED
DiagnaMed Holdings Acquires Exclusive Rights to a Virtual Reality and Artificial Intelligence-based Neurodiagnostic System for Neurodegenerative Disease
From Diagnamed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.